bluebird bio Inc (NAS:BLUE)
$ 0.9624 0.06 (6.64%) Market Cap: 185.50 Mil Enterprise Value: 303.88 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 25/100

bluebird bio Inc at Jefferies Cell Therapy Summit Transcript

Oct 06, 2020 / 06:00PM GMT
Release Date Price: $36.3 (-0.07%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Welcome, everyone. Day 2 of Jeffrey Cell Therapy Summit. We've got bluebird bio. But before I introduce them, I've got my colleague, Kelly Shi, who's on my team, who is going to help moderate this fireside chat.

So I'd like to introduce Philip Gregory, bluebird's Chief Scientific Officer; and Chip Baird, their Chief Financial Officer.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

So maybe, I guess, let's just start off with overview. What can we expect in terms of data at ASH? Can you just talk about maybe things that we should expect over the next few months from the pipeline?

William D. Baird
bluebird bio, Inc. - CFO

Yes, sure. Thanks, Biren, and thanks for inviting us to be a part of the conference day. It's great to be here in a virtual setting. So yes, I think it's going to be an eventful fourth quarter for us, it's been an eventful year so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot